CX Institutional Buys 1,832 Shares of Cigna Group $CI

CX Institutional raised its position in shares of Cigna Group (NYSE:CI) by 5.7% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 33,831 shares of the health services provider’s stock after acquiring an additional 1,832 shares during the period. CX Institutional’s holdings in Cigna Group were worth $9,326,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Wilkerson Advisory Group LLC bought a new position in Cigna Group during the 4th quarter worth $25,000. Kemnay Advisory Services Inc. bought a new position in Cigna Group during the fourth quarter worth about $29,000. Prosperity Bancshares Inc acquired a new stake in Cigna Group in the 4th quarter worth about $29,000. Cedar Mountain Advisors LLC grew its position in shares of Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after purchasing an additional 68 shares in the last quarter. Finally, Creative Financial Designs Inc. ADV raised its position in shares of Cigna Group by 147.3% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock valued at $37,000 after buying an additional 81 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

CI has been the topic of a number of analyst reports. Guggenheim increased their price target on Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a research report on Friday. Jefferies Financial Group decreased their price target on Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research report on Monday, April 20th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a research report on Monday, June 1st. Piper Sandler dropped their target price on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research report on Wednesday, June 3rd. Finally, Wolfe Research reiterated an “outperform” rating and set a $315.00 price target on shares of Cigna Group in a research report on Tuesday, June 16th. Sixteen investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $340.60.

Cigna Group Price Performance

CI stock opened at $282.27 on Tuesday. The company has a market capitalization of $74.59 billion, a P/E ratio of 11.68, a PEG ratio of 1.07 and a beta of 0.29. The company has a fifty day moving average price of $286.54 and a 200-day moving average price of $281.21. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The business had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.Cigna Group’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the business posted $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities analysts expect that Cigna Group will post 30.5 EPS for the current year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a $1.56 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is presently 25.82%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.